Filter by year
-
february172020
Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia
-
february42020
Newron Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference in New York
-
january92020
Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA